Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KIT2014 in moderate to severe COPD
NCT07668518Phase 2Recruiting
- Sponsor
- Kither Biotech
- Start
- Aug 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 2 trial of KIT2014 in chronic obstructive pulmonary disease (COPD), sponsored by Kither Biotech. Started Aug 2026; status: recruiting.
02
Drugs
KIT2014
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07668518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668518.